Brigham Michael F

ImmuCell Corp.

President & CEO, Director

Avg. Two Year Performance

135% Avg. Purchase Return 53% Compound

No Sale Track Record

Holdings: 204.75K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions